Acurx Pharmaceuticals, Inc. (ACXP) vs CNS Pharmaceuticals, Inc. (CNSP)

Acurx Pharmaceuticals, Inc. and CNS Pharmaceuticals, Inc. are both Biotechnology companies. Acurx Pharmaceuticals, Inc. and CNS Pharmaceuticals, Inc. are of similar size ($7.6M and $7.5M). Across the 8 metrics below, CNS Pharmaceuticals, Inc. leads on 5 and Acurx Pharmaceuticals, Inc. on 3.

Valuation

Metric ACXP CNSP Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.71 1.85 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.63 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (197.79%) (478.50%) (28.84%)
Free cash flow yield (106.74%) (39.88%) (23.03%)

Profitability

Metric ACXP CNSP Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (128.11%) (106.62%) (57.72%)
Return on assets (87.57%) (91.64%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACXP CNSP Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 69.43% 92.34% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACXP CNSP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.88 5.86 4.73
Net debt to EBITDA 0.93 0.45 0.96

Dividend

Metric ACXP CNSP Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ACXP CNSP Biotechnology median
Market cap 7.56m 7.53m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack